TY - JOUR
T1 - Severe infections in thalassaemic patients
T2 - Prevalence and predisposing factors
AU - Rahav, Galia
AU - Volach, Vania
AU - Shapiro, Mervyn
AU - Rund, Deborah
AU - Rachmilewitz, Eliezer A.
AU - Goldfarb, Ada
PY - 2006/6
Y1 - 2006/6
N2 - The incidence of infections among patients with thalassaemia and the role of risk factors for infection are uncertain. We studied the occurrence of infections necessitating hospitalisation in 92 homozygous β-thalassaemia patients who had been followed longitudinally for decades, and investigated the role of potential risk factors for these infections. Pneumonia accounted for 26% of the infections and fever of unknown origin for 14%. Staphylococcus aureus was the major pathogen possibly related to injections associated with intensive chelation with deferoxamine. There was a significant increase in the rate of infection over time, notably after 15 years. Splenectomy correlated with the incidence of infection (P < 0.001) without being confounded by other variables and with highest frequencies of infections present after 10 years. A direct correlation between iron overload and infection was evident only before the initiation of iron-chelating treatment (P < 0.01). Following initiation of deferoxamine, paradoxically, the infection rate increased (P = 0.046). The combination of splenectomy and deferoxamine treatment was associated with the highest adjusted infection rate. Parathyroid dysfunction and glucose-6-phosphate dehydrogenase deficiency were significantly associated with infection (P = 0.02 and P = 0.04 respectively). The infection rate in thalassaemia is affected mainly by the duration of the disease and is increased by splenectomy and, in the long term, by treatment with deferoxamine.
AB - The incidence of infections among patients with thalassaemia and the role of risk factors for infection are uncertain. We studied the occurrence of infections necessitating hospitalisation in 92 homozygous β-thalassaemia patients who had been followed longitudinally for decades, and investigated the role of potential risk factors for these infections. Pneumonia accounted for 26% of the infections and fever of unknown origin for 14%. Staphylococcus aureus was the major pathogen possibly related to injections associated with intensive chelation with deferoxamine. There was a significant increase in the rate of infection over time, notably after 15 years. Splenectomy correlated with the incidence of infection (P < 0.001) without being confounded by other variables and with highest frequencies of infections present after 10 years. A direct correlation between iron overload and infection was evident only before the initiation of iron-chelating treatment (P < 0.01). Following initiation of deferoxamine, paradoxically, the infection rate increased (P = 0.046). The combination of splenectomy and deferoxamine treatment was associated with the highest adjusted infection rate. Parathyroid dysfunction and glucose-6-phosphate dehydrogenase deficiency were significantly associated with infection (P = 0.02 and P = 0.04 respectively). The infection rate in thalassaemia is affected mainly by the duration of the disease and is increased by splenectomy and, in the long term, by treatment with deferoxamine.
KW - Deferoxamine
KW - Glucose-6-phosphate dehydrogenase deficiency
KW - Infection
KW - Splenectomy
KW - Thalassaemia
UR - http://www.scopus.com/inward/record.url?scp=33646701893&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2141.2006.06082.x
DO - 10.1111/j.1365-2141.2006.06082.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 16704445
AN - SCOPUS:33646701893
SN - 0007-1048
VL - 133
SP - 667
EP - 674
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 6
ER -